EC Number | Activating Compound | Comment | Organism | Structure |
---|---|---|---|---|
3.5.3.15 | additional information | ionomycin induces PADI4 expression | Homo sapiens |
EC Number | Cloned (Comment) | Organism |
---|---|---|
3.5.3.15 | gene padi4, DNA and amino acid sequence determination and analysis of wild-type and mutant enzymes | Homo sapiens |
EC Number | Protein Variants | Comment | Organism |
---|---|---|---|
3.5.3.15 | A82V/A112G | naturally occuring single-nucleotide polymorphisms and site-directed mutagenesis, the SNP-PADI4 mutant haplotype shows a higher risk of rheumatoid arthritis due to correlation with the RA gene, because the mutant shows increased activity, compared to the wild-type PADI4, which promotes the autoimmune disease and apoptosis, overview | Homo sapiens |
3.5.3.15 | S55G/A112G | naturally occuring single-nucleotide polymorphisms and site-directed mutagenesis, the SNP-PADI4 mutant haplotype shows a higher risk of rheumatoid arthritis due to correlation with the RA gene, because the mutant shows increased activity, compared to the wild-type PADI4, which promotes the autoimmune disease and apoptosis, overview | Homo sapiens |
3.5.3.15 | S55G/A82V | naturally occuring single-nucleotide polymorphisms and site-directed mutagenesis, the SNP-PADI4 mutant haplotype shows reduced activity compared to the wild-type PADI4 | Homo sapiens |
3.5.3.15 | S55G/A82V/A112G | naturally occuring single-nucleotide polymorphisms and site-directed mutagenesis, the SNP-PADI4 mutant haplotype shows a higher risk of rheumatoid arthritis due to correlation with the RA gene, because the mutant shows increased activity, compared to the wild-type PADI4, which promotes the autoimmune disease and apoptosis, overview | Homo sapiens |
EC Number | Metals/Ions | Comment | Organism | Structure |
---|---|---|---|---|
3.5.3.15 | Ca2+ | required | Homo sapiens |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.5.3.15 | protein-L-arginine + H2O | Homo sapiens | posttranslational convertion, PADI4 plays an essential role in immune cell differentiation and apoptosis, ionomycin-inducible PADI4-decreased cell viability and PADI4-enhanced apoptosis, overview | protein-L-citrulline + NH3 | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.5.3.15 | Homo sapiens | - |
gene padi4, isozyme PADI4 | - |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
3.5.3.15 | JURKAT cell | T-cell leukemia cell line with tetracycline resistance | Homo sapiens | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.5.3.15 | protein-L-arginine + H2O | - |
Homo sapiens | protein-L-citrulline + NH3 | - |
? | |
3.5.3.15 | protein-L-arginine + H2O | posttranslational convertion, PADI4 plays an essential role in immune cell differentiation and apoptosis, ionomycin-inducible PADI4-decreased cell viability and PADI4-enhanced apoptosis, overview | Homo sapiens | protein-L-citrulline + NH3 | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
3.5.3.15 | PADI4 | - |
Homo sapiens |
3.5.3.15 | peptidylarginine deiminase IV | - |
Homo sapiens |
EC Number | Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|---|
3.5.3.15 | 37 | - |
assay at | Homo sapiens |
EC Number | pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|---|
3.5.3.15 | 7.5 | - |
assay at | Homo sapiens |